REFERENCES
- Spector, Jesse I. et al. “Sweet’s Syndrome: Association With Acute
Leukemia.” JAMA 244 (1980): 1131-1132.
- Kazmi SM, Pemmaraju N, Patel KP, et al. Characteristics of Sweet
Syndrome in patients with acute myeloid leukemia. Clin Lymphoma
Myeloma Leuk . 2015;15(6):358-363. 10.1016/j.clml.2014.12.009
- Elgarten CW, Aplenc R. Pediatric acute myeloid leukemia: updates on
biology, risk stratification, and therapy. Curr Opin Pediatr .
2020;32(1):57-66. 10.1097/MOP.0000000000000855
- Lonetti A, Pession A, Masetti R. Targeted Therapies for Pediatric AML:
Gaps and Perspective. Front Pediatr . 2019;7:463. Published 2019
Nov 15. 10.3389/fped.2019.00463
- Halpern J, Salim A. Pediatric sweet syndrome: case report and
literature review. Pediatr Dermatol . 2009;26(4):452-457.
10.1111/j.1525-1470.2009.00952.x
- Cohen PR. Sweet’s syndrome–a comprehensive review of an acute
febrile neutrophilic dermatosis. Orphanet J Rare Dis .
2007;2:34. Published 2007 Jul 26. 10.1186/1750-1172-2-34
- El-Khalawany M, Aboeldahab S, Mosbeh AS, Thabet A. Clinicopathologic,
immunophenotyping and cytogenetic analysis of Sweet syndrome in
Egyptian patients with acute myeloid leukemia. Pathol Res
Pract . 2017;213(2):143-153. 10.1016/j.prp.2016.10.008
- Alegría-Landa V, Rodríguez-Pinilla SM, Santos-Briz A, et al.
Clinicopathologic, Immunohistochemical, and Molecular Features of
Histiocytoid Sweet Syndrome. JAMA Dermatol .
2017;153(7):651-659. 10.1001/jamadermatol.2016.6092
- Maller B, Bigness A, Moiño D, Greene J. Sweet’s syndrome associated
with hematological malignancies. Leuk Res . 2020;99:106461.
10.1016/j.leukres.2020.106461
- Chan MP, Duncan LM, Nazarian RM. Subcutaneous Sweet syndrome in the
setting of myeloid disorders: a case series and review of the
literature. J Am Acad Dermatol . 2013;68(6):1006-1015.
10.1016/j.jaad.2012.12.954
- Passet M, Lepelletier C, Vignon-Pennamen MD, et al. Next-Generation
Sequencing in Myeloid Neoplasm-Associated Sweet’s Syndrome
Demonstrates Clonal Relation between Malignant Cells and
Skin-Infiltrating Neutrophils. J Invest Dermatol .
2020;140(9):1873-1876.e5. 10.1016/j.jid.2019.12.040
- Kaddu S, Zenahlik P, Beham-Schmid C, Kerl H, Cerroni L. Specific
cutaneous infiltrates in patients with myelogenous leukemia: a
clinicopathologic study of 26 patients with assessment of diagnostic
criteria. J Am Acad Dermatol . 1999;40(6 Pt 1):966-978.
10.1016/s0190-9622(99)70086-1
- Behm FG, Kay S, Aportela R. Febrile neutrophilic dermatosis associated
with acute leukemia. Am J Clin Pathol . 1981;76(3):344-347.
10.1093/ajcp/76.3.344
- Paul S, Jammal N, Akhave N, et al. Atypical cases of necrotizing sweet
syndrome in patients with myelodysplastic syndrome and acute myeloid
leukaemia. Br J Haematol . 2020;191(1):e10-e13.
doi:10.1111/bjh.16937
- Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet’s
syndrome: review of the world literature. J Clin Oncol .
1988;6(12):1887-1897. 10.1200/JCO.1988.6.12.1887
LEGENDS
Figure 1: A) Diffuse erythematous, raised, tender papules and
plaques distributed over arms and hands. B) Histopathology of the biopsy
showed mildly spongiotic epidermis with an occasional necrotic
keratinocyte[arrow] overlying an oedematous dermis with a prominent
neutrophilic infiltrate[arrow head].